Ameriprise’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-66,061
Closed -$2.44M 3902
2023
Q3
$2.44M Buy
66,061
+20,116
+44% +$744K ﹤0.01% 2729
2023
Q2
$1.85M Sell
45,945
-13,250
-22% -$533K ﹤0.01% 2917
2023
Q1
$4.29M Buy
59,195
+5,858
+11% +$425K ﹤0.01% 2419
2022
Q4
$4.38M Buy
53,337
+18,434
+53% +$1.51M ﹤0.01% 2379
2022
Q3
$3.3M Sell
34,903
-8,320
-19% -$786K ﹤0.01% 2517
2022
Q2
$8.42M Sell
43,223
-11,035
-20% -$2.15M ﹤0.01% 1870
2022
Q1
$12.6M Buy
54,258
+7,207
+15% +$1.67M ﹤0.01% 1716
2021
Q4
$18.5M Buy
47,051
+16,972
+56% +$6.69M 0.01% 1477
2021
Q3
$13.5M Buy
30,079
+415
+1% +$186K ﹤0.01% 1599
2021
Q2
$11.5M Buy
29,664
+9,088
+44% +$3.53M ﹤0.01% 1824
2021
Q1
$7.39M Buy
20,576
+7,627
+59% +$2.74M ﹤0.01% 2121
2020
Q4
$6.36M Sell
12,949
-2,231
-15% -$1.09M ﹤0.01% 2096
2020
Q3
$4.92M Sell
15,180
-720
-5% -$233K ﹤0.01% 2100
2020
Q2
$5.79M Sell
15,900
-1,359
-8% -$495K ﹤0.01% 1957
2020
Q1
$3.67M Buy
17,259
+4,010
+30% +$853K ﹤0.01% 2113
2019
Q4
$5.45M Buy
13,249
+176
+1% +$72.4K ﹤0.01% 2183
2019
Q3
$4.62M Buy
13,073
+2,734
+26% +$965K ﹤0.01% 2252
2019
Q2
$5.2M Buy
10,339
+137
+1% +$68.9K ﹤0.01% 2233
2019
Q1
$10.1M Buy
10,202
+4,974
+95% +$4.94M ﹤0.01% 1695
2018
Q4
$4.54M Sell
5,228
-1,898
-27% -$1.65M ﹤0.01% 2180
2018
Q3
$7.37M Sell
7,126
-5,111
-42% -$5.28M ﹤0.01% 2097
2018
Q2
$11.2M Sell
12,237
-4,737
-28% -$4.35M 0.01% 1639
2018
Q1
$16.5M Buy
+16,974
New +$16.5M 0.01% 1262